Cristina Iribarren
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis.
Journal: The Journal of molecular diagnostics : JMD
Published: February 13, 2024
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome.
Journal: Neurogastroenterology and motility
Published: March 30, 2023
Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids.
Journal: International journal of molecular sciences
Published: October 20, 2022
Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review.
Journal: Gut microbiome (Cambridge, England)
Published: January 21, 2022
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids.
Journal: Neurogastroenterology and motility
Published: November 04, 2021
The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Journal: Nutrients
Published: September 23, 2021
Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study.
Journal: Neurogastroenterology and motility
Published: February 28, 2020
Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction.
Journal: Scientific reports
Published: September 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026